Cargando…
Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
Discrimination of pancreatic ductal adenocarcinoma (PDAC) from chronic pancreatitis (CP) or peritumoral inflammation is challenging, both at preoperative imaging and during surgery, but it is crucial for proper therapy selection. Tumor-specific molecular imaging aims to enhance this discrimination a...
Autores principales: | Tummers, Willemieke S., Farina-Sarasqueta, Arantza, Boonstra, Martin C., Prevoo, Hendrica A., Sier, Cornelis F., Mieog, Jan S., Morreau, Johannes, van Eijck, Casper H., Kuppen, Peter J., van de Velde, Cornelis J., Bonsing, Bert A., Vahrmeijer, Alexander L., Swijnenburg, Rutger-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593604/ https://www.ncbi.nlm.nih.gov/pubmed/28915633 http://dx.doi.org/10.18632/oncotarget.18232 |
Ejemplares similares
-
Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery
por: de Geus, Susanna W. L., et al.
Publicado: (2016) -
Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells
por: de Geus, Susanna WL, et al.
Publicado: (2017) -
Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy
por: Boogerd, Leonora SF, et al.
Publicado: (2018) -
CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
por: Linders, Daan, et al.
Publicado: (2021) -
Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
por: Boonstra, Martin C, et al.
Publicado: (2014)